Applied Therapeutics, Inc. (APLT) Financials
APLT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 54.8 million | 72.0 million |
2023-09-30 | 45.2 million | 56.2 million |
2023-06-30 | 43.6 million | 48.0 million |
2023-03-31 | 30.0 million | 34.1 million |
APLT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -17.0 million | 1.6 million |
2023-09-30 | -14.7 million | 1.8 million |
2023-06-30 | -16.5 million | 1.8 million |
2023-03-31 | -7.0 million | 2.1 million |
APLT Net Income
No data available :(
APLT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 49.9 million | - | 467000 |
2023-09-30 | 37.5 million | - | 535000 |
2023-06-30 | 35.6 million | - | 656000 |
2023-03-31 | 22.9 million | - | 774000 |
APLT Shares Outstanding
APLT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 15.3 million | 5.0 million | - |
2023-09-30 | - | 10.8 million | 4.7 million | - |
2023-06-30 | - | 11.9 million | 5.3 million | - |
2023-03-31 | - | 15.9 million | 5.6 million | - |
APLT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | -667000 | 347000 |
2023-09-30 | - | 118000 |
2023-06-30 | - | 115000 |
2023-03-31 | 10.7 million | 114000 |
APLT
Price: $4.71
52 week price:
Earnings Per Share: -1.42 USD
P/E Ratio: -2.42
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 546852
Market Capitalization: 657.6 million